Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paracoccidioides | 34 | 2015 | 37 | 3.240 |
Why?
|
| Paracoccidioidomycosis | 23 | 2015 | 25 | 2.720 |
Why?
|
| Histoplasmosis | 10 | 2018 | 24 | 1.670 |
Why?
|
| Antifungal Agents | 12 | 2014 | 135 | 1.520 |
Why?
|
| Lung Diseases, Fungal | 7 | 2015 | 35 | 1.100 |
Why?
|
| Histoplasma | 7 | 2018 | 16 | 0.780 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2016 | 136 | 0.710 |
Why?
|
| Coinfection | 5 | 2021 | 58 | 0.710 |
Why?
|
| Spores, Fungal | 7 | 2015 | 26 | 0.690 |
Why?
|
| Triazoles | 3 | 2006 | 66 | 0.640 |
Why?
|
| Adrenal Insufficiency | 2 | 2010 | 10 | 0.620 |
Why?
|
| Adrenal Glands | 2 | 2010 | 34 | 0.610 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2018 | 68 | 0.590 |
Why?
|
| Lung | 11 | 2013 | 972 | 0.520 |
Why?
|
| Fluconazole | 2 | 2014 | 13 | 0.490 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 10 | 0.440 |
Why?
|
| Antigens, Fungal | 5 | 2018 | 58 | 0.430 |
Why?
|
| Mice, Inbred BALB C | 19 | 2015 | 892 | 0.420 |
Why?
|
| Cryptococcosis | 1 | 2014 | 79 | 0.410 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 286 | 0.400 |
Why?
|
| Cryptococcus neoformans | 1 | 2014 | 148 | 0.400 |
Why?
|
| Tuberculosis | 2 | 2016 | 305 | 0.390 |
Why?
|
| Itraconazole | 4 | 2012 | 14 | 0.340 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 473 | 0.310 |
Why?
|
| Hydrocortisone | 1 | 2010 | 194 | 0.290 |
Why?
|
| Fungal Proteins | 5 | 2013 | 152 | 0.280 |
Why?
|
| Postoperative Complications | 2 | 2004 | 1326 | 0.240 |
Why?
|
| Salvage Therapy | 1 | 2006 | 75 | 0.240 |
Why?
|
| Male | 27 | 2025 | 31067 | 0.240 |
Why?
|
| Leptospirosis | 1 | 2025 | 2 | 0.230 |
Why?
|
| Colombia | 8 | 2018 | 23 | 0.230 |
Why?
|
| Skin | 1 | 2008 | 424 | 0.220 |
Why?
|
| Candidiasis | 1 | 2004 | 53 | 0.210 |
Why?
|
| Amphotericin B | 2 | 2014 | 23 | 0.210 |
Why?
|
| Mucormycosis | 1 | 2003 | 10 | 0.200 |
Why?
|
| Oxidoreductases | 2 | 2015 | 64 | 0.200 |
Why?
|
| Humans | 34 | 2025 | 65536 | 0.190 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2014 | 93 | 0.190 |
Why?
|
| Plant Proteins | 2 | 2015 | 93 | 0.190 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 108 | 0.190 |
Why?
|
| Soil Microbiology | 1 | 2002 | 11 | 0.190 |
Why?
|
| Mice | 20 | 2015 | 11209 | 0.180 |
Why?
|
| Adult | 13 | 2025 | 17411 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2008 | 37 | 0.180 |
Why?
|
| Virulence Factors | 2 | 2013 | 86 | 0.180 |
Why?
|
| Opisthorchiasis | 1 | 2021 | 1 | 0.180 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 116 | 0.180 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 2294 | 0.180 |
Why?
|
| Strongyloidiasis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Antibodies, Fungal | 4 | 2011 | 13 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2002 | 183 | 0.160 |
Why?
|
| Animals | 22 | 2025 | 21533 | 0.160 |
Why?
|
| Cytokines | 6 | 2011 | 956 | 0.160 |
Why?
|
| Middle Aged | 11 | 2025 | 18262 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6880 | 0.160 |
Why?
|
| Anti-HIV Agents | 2 | 2014 | 146 | 0.150 |
Why?
|
| Fibrinogen | 3 | 2008 | 33 | 0.150 |
Why?
|
| Fibronectins | 3 | 2008 | 44 | 0.150 |
Why?
|
| HIV Infections | 3 | 2016 | 965 | 0.150 |
Why?
|
| Self Care | 2 | 2011 | 215 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2511 | 0.140 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 26 | 0.140 |
Why?
|
| Microbial Viability | 3 | 2015 | 58 | 0.140 |
Why?
|
| Macrophage Activation | 3 | 2008 | 118 | 0.140 |
Why?
|
| Female | 14 | 2025 | 34115 | 0.130 |
Why?
|
| Adolescent | 8 | 2025 | 6378 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 1 | 2016 | 35 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 45 | 0.120 |
Why?
|
| Phylogeny | 3 | 2007 | 395 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 93 | 0.120 |
Why?
|
| Mycelium | 3 | 2015 | 4 | 0.120 |
Why?
|
| Macrophages, Peritoneal | 2 | 2007 | 76 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2014 | 214 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2013 | 127 | 0.110 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2014 | 14 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 251 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 46 | 0.110 |
Why?
|
| Viral Load | 1 | 2014 | 228 | 0.100 |
Why?
|
| HIV | 1 | 2013 | 70 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 726 | 0.100 |
Why?
|
| Deoxycholic Acid | 1 | 2012 | 7 | 0.100 |
Why?
|
| Macrophages | 5 | 2013 | 1060 | 0.100 |
Why?
|
| Recurrence | 1 | 2014 | 660 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2014 | 205 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 741 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 1172 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 171 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2010 | 1672 | 0.090 |
Why?
|
| Dihydropteroate Synthase | 1 | 2012 | 6 | 0.090 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 22 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 207 | 0.090 |
Why?
|
| Pneumocystis carinii | 1 | 2012 | 8 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 100 | 0.090 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2012 | 19 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2003 | 81 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2013 | 189 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 524 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 65 | 0.090 |
Why?
|
| Young Adult | 6 | 2025 | 4832 | 0.090 |
Why?
|
| Aged | 7 | 2025 | 14942 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 131 | 0.090 |
Why?
|
| Poverty | 2 | 2011 | 307 | 0.090 |
Why?
|
| Melanins | 1 | 2011 | 27 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 460 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2010 | 216 | 0.090 |
Why?
|
| Pheromones | 1 | 2011 | 22 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2018 | 2632 | 0.080 |
Why?
|
| Risk Factors | 3 | 2025 | 5441 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2011 | 2077 | 0.080 |
Why?
|
| Pentoxifylline | 1 | 2010 | 8 | 0.080 |
Why?
|
| Laminin | 2 | 2008 | 81 | 0.080 |
Why?
|
| Estrogens | 1 | 2011 | 117 | 0.080 |
Why?
|
| Histocytochemistry | 4 | 2011 | 47 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 80 | 0.080 |
Why?
|
| Health Literacy | 1 | 2011 | 87 | 0.080 |
Why?
|
| Genotype | 1 | 2012 | 679 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2010 | 109 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 801 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 2013 | 582 | 0.080 |
Why?
|
| Mycological Typing Techniques | 2 | 2006 | 2 | 0.070 |
Why?
|
| Biopsy | 2 | 2009 | 457 | 0.070 |
Why?
|
| Fludrocortisone | 1 | 2009 | 4 | 0.070 |
Why?
|
| Prednisone | 1 | 2009 | 86 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2007 | 181 | 0.070 |
Why?
|
| X-Rays | 1 | 2008 | 47 | 0.070 |
Why?
|
| Muramidase | 1 | 2008 | 47 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2008 | 67 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2008 | 102 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 265 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 623 | 0.070 |
Why?
|
| Chitin Synthase | 1 | 2007 | 12 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 175 | 0.060 |
Why?
|
| Ferrous Compounds | 1 | 2007 | 13 | 0.060 |
Why?
|
| Ethmoid Sinusitis | 1 | 2006 | 1 | 0.060 |
Why?
|
| Maxillary Sinusitis | 1 | 2006 | 4 | 0.060 |
Why?
|
| Meningitis, Fungal | 1 | 2006 | 2 | 0.060 |
Why?
|
| Radiography | 1 | 2008 | 557 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 42 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 29 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 154 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 22 | 0.060 |
Why?
|
| Health Behavior | 1 | 2009 | 482 | 0.060 |
Why?
|
| Complement C3 | 1 | 2006 | 59 | 0.060 |
Why?
|
| Adhesiveness | 1 | 2005 | 13 | 0.060 |
Why?
|
| Spatial Regression | 1 | 2025 | 1 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 90 | 0.060 |
Why?
|
| Genetic Speciation | 1 | 2005 | 15 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2025 | 25 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 94 | 0.060 |
Why?
|
| Women | 1 | 2005 | 44 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2021 | 126 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2011 | 818 | 0.060 |
Why?
|
| Infant | 2 | 2011 | 1718 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1049 | 0.050 |
Why?
|
| Molecular Sequence Data | 5 | 2006 | 2016 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 255 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 44 | 0.050 |
Why?
|
| Culture Media | 2 | 2015 | 80 | 0.050 |
Why?
|
| Abdomen | 1 | 2004 | 95 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2003 | 56 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 431 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 1618 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2005 | 401 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 388 | 0.050 |
Why?
|
| Fungi | 1 | 2003 | 62 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 41 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 800 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2004 | 160 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 106 | 0.050 |
Why?
|
| Mycoses | 1 | 2003 | 71 | 0.050 |
Why?
|
| RNA, Antisense | 2 | 2013 | 51 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 468 | 0.050 |
Why?
|
| Opisthorchis | 1 | 2021 | 1 | 0.040 |
Why?
|
| Strongyloides stercoralis | 1 | 2021 | 12 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2003 | 179 | 0.040 |
Why?
|
| Thailand | 1 | 2021 | 98 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 713 | 0.040 |
Why?
|
| DNA, Fungal | 2 | 2012 | 58 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 5609 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2007 | 424 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 330 | 0.040 |
Why?
|
| Child | 2 | 2011 | 4681 | 0.040 |
Why?
|
| Microscopy | 2 | 2011 | 100 | 0.040 |
Why?
|
| Family | 1 | 2002 | 247 | 0.040 |
Why?
|
| Protein Binding | 3 | 2013 | 1651 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 2068 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1575 | 0.040 |
Why?
|
| Weight Loss | 2 | 2016 | 278 | 0.040 |
Why?
|
| Guatemala | 1 | 2018 | 4 | 0.040 |
Why?
|
| Galactose | 1 | 2018 | 13 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1410 | 0.040 |
Why?
|
| Mannans | 1 | 2018 | 21 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2699 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2011 | 93 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 1441 | 0.030 |
Why?
|
| Life Cycle Stages | 2 | 2008 | 18 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2016 | 2 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 12 | 0.030 |
Why?
|
| Leukopenia | 1 | 2016 | 15 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2016 | 22 | 0.030 |
Why?
|
| Skin Ulcer | 1 | 2016 | 14 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2007 | 124 | 0.030 |
Why?
|
| Lymphadenopathy | 1 | 2016 | 22 | 0.030 |
Why?
|
| Pneumonia | 2 | 2010 | 293 | 0.030 |
Why?
|
| Time Factors | 3 | 2011 | 3788 | 0.030 |
Why?
|
| Headache | 1 | 2016 | 58 | 0.030 |
Why?
|
| Diarrhea | 1 | 2016 | 76 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 2 | 2006 | 30 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 55 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 112 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2016 | 104 | 0.030 |
Why?
|
| Dyspnea | 1 | 2016 | 124 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 139 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 877 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5818 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 906 | 0.030 |
Why?
|
| Species Specificity | 2 | 2006 | 348 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2007 | 269 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 184 | 0.030 |
Why?
|
| Mutation | 2 | 2013 | 2680 | 0.030 |
Why?
|
| Immunodiffusion | 1 | 2013 | 5 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 26 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2013 | 52 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 1114 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1700 | 0.030 |
Why?
|
| Base Sequence | 2 | 2006 | 1346 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2013 | 107 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 185 | 0.020 |
Why?
|
| Oxidants | 1 | 2011 | 19 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 325 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 2011 | 6 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 86 | 0.020 |
Why?
|
| Serum | 1 | 2011 | 28 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 316 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 113 | 0.020 |
Why?
|
| Latin America | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2011 | 137 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 199 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 71 | 0.020 |
Why?
|
| Symptom Assessment | 1 | 2011 | 49 | 0.020 |
Why?
|
| Reticulin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2011 | 62 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 250 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 259 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 323 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2010 | 33 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2010 | 56 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 109 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 590 | 0.020 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2009 | 3 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 318 | 0.020 |
Why?
|
| Hydrolases | 1 | 2010 | 82 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 134 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 867 | 0.020 |
Why?
|
| Yeasts | 1 | 2010 | 48 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 421 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 118 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 603 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 461 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 612 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 201 | 0.020 |
Why?
|
| Community Health Services | 1 | 2009 | 127 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2008 | 5 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 432 | 0.020 |
Why?
|
| Chitin | 1 | 2008 | 39 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 103 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 997 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 1123 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2009 | 296 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 757 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2214 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Counseling | 1 | 2009 | 378 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3355 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 918 | 0.020 |
Why?
|
| Sulfur | 1 | 2006 | 16 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 51 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 134 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2006 | 68 | 0.020 |
Why?
|
| Methylmannosides | 1 | 2006 | 2 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2006 | 22 | 0.020 |
Why?
|
| Transferrin | 1 | 2007 | 70 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2006 | 19 | 0.020 |
Why?
|
| Research Design | 1 | 2009 | 585 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 376 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2006 | 131 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 197 | 0.010 |
Why?
|
| South America | 1 | 2005 | 26 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 801 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 31 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2005 | 14 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 15 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 2005 | 30 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 54 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 301 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 193 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 419 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2006 | 266 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 457 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 238 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 405 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 72 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 2149 | 0.010 |
Why?
|
| Diffusion | 1 | 2003 | 82 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 742 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 923 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3152 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 384 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 619 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 1186 | 0.010 |
Why?
|